Sort
85,873 grants matching “alzheimers”
From Structure to Therapy: The TRiC Chaperonin Network in Huntington's Disease
$1,312,360Leslie Michels Thompson · University Of California-Irvine · P01 · FY2017 · NS
Upregulated Norepinephrine Synthesis Capacity in Aging
$1,312,304Anne Shively Berry · Brandeis University · R01 · FY2025 · AG
NINDS Human Cell and Data Repository (U24)
$1,312,236Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2021 · NS
UC Davis Alzheimer's Disease Core Center
$1,312,222Charles Decarli · University Of California At Davis · P30 · FY2012 · AG
METRIcAL - Music & MEmory: a Pragmatic TRIal for Nursing Home Residents with ALzheimer's Disease
$1,312,119Vincent Mor · Brown University · R33 · FY2018 · AG
Core A: Administrative Core
$1,311,852Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U19 · FY2023 · AG
From Structure to Therapy: The TRiC Chaperonin Network in Huntington's Disease
$1,311,829Leslie Michels Thompson · University Of California-Irvine · P01 · FY2016 · NS
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
$1,311,510Carol A. Shively · Wake Forest University Health Sciences · R24 · FY2021 · AG
Lipid transport, oxidation and toxicity in the retina
$1,311,127Ignacio R Rodriguez · National Eye Institute · ZIA · FY2011 · EY
The influence of familial social context on risk dissemination and coping
$1,311,016Laura M Koehly · National Human Genome Research Institute · ZIA · FY2013 · HG
Adult Changes in Thought (ACT) Research Program Core D: Neuropathology Core
$1,310,728Christopher D Keene · Kaiser Foundation Research Institute · U19 · FY2021 · AG
PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment
$1,310,572Michela Gallagher · Johns Hopkins University · R01 · FY2021 · AG
Risk for Alzheimer's Disease and Cognitive Decline in Project TALENT
$1,310,273Carol A. Prescott · University Of Southern California · R01 · FY2016 · AG
Marinobufagenin as a therapeutic target
$1,310,148Edward Lakatta · National Institute On Aging · ZIA · FY2022 · AG
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2023 · NS
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2024 · NS
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2025 · NS
Mechanisms of Aging in the Olfactory System
$1,309,915Charles A Greer · Yale University · P01 · FY2006 · AG
University of Kentucky Alzheimer's Disease Core Center
$1,309,812Linda J Van Eldik · University Of Kentucky · P30 · FY2015 · AG
TAU AND NEURODEGENERATION
$1,309,657Mayo Clinic Coll Of Med, Jacksonville · P01 · FY2003 · AG
PharmaScan 70/16 In-Vivo Spectroscopy/Imaging System
$1,309,550Arizona State University-Tempe Campus · S10 · FY2005 · RR
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)
$1,309,221Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2025 · AG
Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies
$1,308,839Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease
$1,308,813Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2018 · AG
Micronutrients, stroke and cognition in aging
$1,308,683Tufts University Boston · R01 · FY2003 · AG